BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 455758)

  • 21. [Long-term therapy of acromegaly and gigantism by using CB-154].
    Aizawa T; Tawada M; Koizumi Y; Ikejiri K; Kotani M
    Horumon To Rinsho; 1977 Dec; 25(12):1310-5. PubMed ID: 598032
    [No Abstract]   [Full Text] [Related]  

  • 22. Factors determining the effectiveness of CB-154 in the treatment of acromegaly.
    Hanew K; Sasaki A; Sato S; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1983 Jan; 139(1):91-5. PubMed ID: 6404005
    [No Abstract]   [Full Text] [Related]  

  • 23. [CB-154 in the treatment of acromegaly: conclusion].
    Shizume K; Demura R
    Horumon To Rinsho; 1977 Dec; 25(12):1349-53. PubMed ID: 598044
    [No Abstract]   [Full Text] [Related]  

  • 24. Bromocriptine in treatment of acromegaly: Australian experience.
    Lording DW; Burger HG
    Med J Aust; 1978 Nov; 2(3 Suppl):34-5. PubMed ID: 745580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic effect of CB-154 in acromegaly].
    Miyashita M; Kaneko K; Yamada Y
    Horumon To Rinsho; 1977 Dec; 25(12):1306-7. PubMed ID: 598030
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of acromegaly using CB-154 and medroxy-progesterone acetate].
    Ichikawa Y; Yoshida K; Kawagoe M
    Horumon To Rinsho; 1977 Dec; 25(12):1303-4. PubMed ID: 598028
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment with 2-bromo-alpha-ergocriptine (CB 154) in acromegaly associated with diabetes mellitus: especialy about improved glucose tolerance (author's transl)].
    Kobayashi N; Terashi K; Morita S; Oimomi T; Baba S
    Horumon To Rinsho; 1979 Nov; 27(11):1327-31. PubMed ID: 519891
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of acromegaly with bromocriptine.
    Steinbeck K; Turtle JR
    Med J Aust; 1978 Nov; 2(3 Suppl):35-6. PubMed ID: 745581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of CB-154 administration in acromegaly].
    Nakagawa K; Obara T
    Horumon To Rinsho; 1977 Dec; 25(12):1274-6. PubMed ID: 598017
    [No Abstract]   [Full Text] [Related]  

  • 30. [Endocrinologic evaluation of 61 patients with acromegaly treated with transsphenoidal removal alone, or associated with telecobalt irradiation or bromocriptine or both].
    Barceló B; Pérez C; Dávila N; Lucas T; Salto L; Alcañiz J
    Med Clin (Barc); 1983 May; 80(17):735-41. PubMed ID: 6621120
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relationship between suppression of growth hormone by CB-154 and prolactin secretion in acromegaly--indication for a long term care].
    Hara I; Kataoka K; Tomita A; Kuwayama A; Kageyama N
    Horumon To Rinsho; 1977 Dec; 25(12):1316-20. PubMed ID: 413675
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Some alternatives of bromocriptin action of glucose tolerance in acromegalics (author's transl)].
    Dolecek R; Závada M
    Cas Lek Cesk; 1981; 120(51):1568-72. PubMed ID: 7034947
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
    Molitvoslovova NN
    Sov Med; 1984; (1):24-9. PubMed ID: 6701649
    [No Abstract]   [Full Text] [Related]  

  • 35. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 36. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L; Ljunghall S; Wide L; Boström H
    Acta Endocrinol Suppl (Copenh); 1978; 216():207-16. PubMed ID: 347863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of small doses of bromocriptine (Parlodel) on the serum level of growth hormone in acromegaly].
    Gáspár L; László F
    Orv Hetil; 1980 May; 121(20):1179-82. PubMed ID: 7413200
    [No Abstract]   [Full Text] [Related]  

  • 38. Gel filtration studies of serum growth hormone in acromegaly following bromocriptine administration.
    Benker G; Sandmann K; Tharandt L; Hackenberg K; Reinwein D
    Horm Res; 1979; 11(3):151-60. PubMed ID: 488905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine reduces growth hormone in acromegaly.
    Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B
    Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of bromocriptine to alter the qualitative characteristics of human growth hormone in acromegaly.
    Hizuka N; Hendricks CM; Roth J; Gorden P
    Metabolism; 1984 Jun; 33(6):582-4. PubMed ID: 6727657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.